AzTrials
AzTrials

Anorectal MalformationEarly Phase 1NCT07392203

Role of (Saline- Glycerin) Rectal Enema in Treatment of Fecal Incontinence in Children

A Early Phase 1 study testing Rectal enema using saline and glycerin mixture once daily in people with Anorectal Malformation, run by Sohag University at 1 site in Egypt.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Using saline glycerin mixture once daily in children with fecal incontinence to reach aclean child without fecal accidents the next day. Read more about this study

Who is it for?
Ages 3 to 16 years
Conditions the study is for
Anorectal Malformation
What is being tested?
Rectal enema using saline and glycerin mixture once daily
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteEgypt
Study dates
15 Feb 2026to 30 Aug 2026
Phase
Early Phase 1
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 3 to 16 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

None listed.

Who cannot join

  • -

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Suzan Ali Mohammed, Resident of pediatric surgery contact

01143847284

an4562195@gmail.com

Egypt1 site
  • Sohag university

    Sohag

Other trials in Egypt

About this study

Using saline glycerin mixture once daily in children with fecal incontinence to reach aclean child without fecal accidents the next day.

Read the detailed description

Child lies on Lt lateral position. Foley catheter inserted to thr rectum and inflated Instillation of saline glycerin mixture. Child hold it for 15 minutes Foley catheter removed Child stay in bathroom for 45 min

Being tested
Rectal enema using saline and glycerin mixture once daily
Medical subject headings
Anorectal Malformations

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Rectal enema using saline and glycerin mixture once dailyProcedure or surgery

    Rectal enema using saline \& glycerin for treatment of fecal incontinence in children

Study groups in NCT07392203
Study groupRoleWhat they receive
Prospective, single-arm, single-centre interventional study by rectal enema using saline and glyceriExperimentalProspective, single-arm, single-centre interventional study conducted in the Pediatric Surgery Department, Sohag University Hospitals. The protocol adheres to contemporary bowel-management frameworks for pediatric fecal incontinence with daily retrograde enemas and radiographic/clinical titration.
Receives: Procedure: Rectal enema using saline and glycerin mixture once daily

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Proportion of clean days (no stool accidents) during days 7-14 of titration and at week 4.

    Measured: Follow up after 4 weeks and after 12 weeks

  2. Proportion of clean days (no stool accidents) during days 7-14 of titration and at week 4.

    Measured: 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Feb 2026
  2. Study start15 Feb 2026 (estimated)
  3. Primary completion30 Jun 2026 (estimated)
  4. Study completion30 Aug 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Early Phase 1
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07392203
Sponsor's protocol ID
Soh-Med-25-12-13MS
Status last verified
Feb 2026
First submitted
12 Jan 2026
Last updated
6 Feb 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A Early Phase 1 study testing Rectal enema using saline and glycerin mixture once daily in people with Anorectal Malformation, run by Sohag University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 0 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 6 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Early Phase 1 (sometimes called Phase 0) studies give a very small amount of a treatment to a few people, mainly to see how the body handles it.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Suzan Ali Mohammed, Resident of pediatric surgery (01143847284, an4562195@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Proportion of clean days (no stool accidents) during days 7-14 of titration and at week 4. (time frame: Follow up after 4 weeks and after 12 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in